FundedIQ
Biotechnology

Oleander Medical Technologies: Funding, Investors & Team (Sep 2026)

Oleander Medical Technologies is working on an innovative treatment called Targeted Osmotic Lysis (TOL) that has the potential to effectively eliminate aggressive and life-threatening cancers without causing harm to the rest of the body. This process can eradicate cancer quickly, painlessly, and with minimal discomfort, all while being more cost-effective than traditional treatments like radiation or chemotherapy.

www.oleandermedicaltechnologies.com LinkedIn Baton Rouge, United States 1-10 employees
Biotechnology Clinical Trials Communities Medical Device
Total raised
$500k
Rounds
1
Latest
Undisclosed round
Jul 2024

Oleander Medical Technologies has raised $500k across 1 funding round on record, the most recent an undisclosed round of $500k announced in Jul 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Oleander Medical Technologies Company Profile and Key Stats

Total funding raised
$500k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$500k in Jul 2024
Employees
1-10
reported band
Headquarters
Baton Rouge, United States

Latest funding round on record: Jul 2024.

Oleander Medical Technologies Funding Rounds

Date
Round
Amount
Undisclosed round
$500k

Oleander Medical Technologies Founders and Leadership Team

Name
Role
Contact
Dennis Paul
Founder
Locked

Contact details for the Oleander Medical Technologies team: 1 of 1 has an email address on file.

Start 14-day free trial →

Oleander Medical Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Oleander Medical Technologies' latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Oleander Medical Technologies in Biotechnology and Baton Rouge

Companies Similar to Oleander Medical Technologies

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Oleander Medical Technologies Funding FAQs

What does Oleander Medical Technologies do?

Oleander Medical Technologies is working on an innovative treatment called Targeted Osmotic Lysis (TOL) that has the potential to effectively eliminate aggressive and life-threatening cancers without causing harm to the rest of the body. This process can eradicate cancer quickly, painlessly, and with minimal discomfort, all while being more cost-effective than traditional treatments like radiation or chemotherapy.

How much funding has Oleander Medical Technologies raised?

Oleander Medical Technologies has raised $500k across 1 round on record. The most recent is an undisclosed round of $500k announced in Jul 2024.

When did Oleander Medical Technologies last raise funding?

Oleander Medical Technologies' most recent funding round on record is an undisclosed round of $500k, announced in Jul 2024.

Who founded Oleander Medical Technologies?

FundedIQ lists Dennis Paul (Founder) at Oleander Medical Technologies.

Where is Oleander Medical Technologies headquartered?

Oleander Medical Technologies is based in Baton Rouge, Louisiana, United States.

How many employees does Oleander Medical Technologies have?

Oleander Medical Technologies is in the 1-10 employee band.

How does Oleander Medical Technologies' funding compare to other Biotechnology startups?

Oleander Medical Technologies' latest round of $500k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Oleander Medical Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oleander Medical Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.